➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Dow
Express Scripts
Moodys
Baxter

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR COSOPT

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Cosopt

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00140049 ↗ A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma Completed Pfizer Phase 4 2005-07-01 To demonstrate the statistical non inferiority of the combination of latanoprost and timolol given in the evening time once a day vs the combination of dorzamalide and timolol twice a day based on intraocular pressure measurements at 8 AM, 12 noon & 4 PM during a 12 week treatment.
NCT00273429 ↗ Cosopt Versus Xalatan Completed Pharmaceutical Research Network Phase 4 2005-04-01 To compare the 24-hour efficacy and safety, measured every three hours, of the dorzolamide/timolol fixed combination given twice daily versus latanoprost and placebo each given once daily.
NCT00273442 ↗ Assessing Cosopt Switch Patients Completed Pharmaceutical Research Network Phase 4 2005-11-01 To assess the safety and efficacy of a cohort of patients switched to the dorzolamide/timolol maleate fixed combination because they are insufficiently controlled on latanoprost monotherapy.
NCT00273455 ↗ Lumigan Versus Cosopt Completed Pharmaceutical Research Network Phase 4 2006-01-01 To compare the intraocular pressure effect and safety of the dorzolamide/timolol fixed combination given twice daily versus bimatoprost given once every evening in patients with open-angle glaucoma in patients insufficiently controlled on latanoprost monotherapy
NCT00273481 ↗ Cosopt Versus Xalacom Completed Pharmaceutical Research Network Phase 4 2005-09-01 To compare the intraocular pressure efficacy and safety of the DTFC given twice daily versus the LTFC given once every morning following a run-in period with timolol maleate given twice daily.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cosopt

Condition Name

Condition Name for Cosopt
Intervention Trials
Ocular Hypertension 18
Glaucoma 15
Open-Angle Glaucoma 10
Wet Macular Degeneration 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cosopt
Intervention Trials
Glaucoma 25
Ocular Hypertension 19
Glaucoma, Open-Angle 15
Hypertension 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cosopt

Trials by Country

Trials by Country for Cosopt
Location Trials
United States 24
Canada 4
Greece 3
Italy 2
Mexico 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cosopt
Location Trials
Pennsylvania 3
Massachusetts 3
Michigan 2
Indiana 2
Texas 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cosopt

Clinical Trial Phase

Clinical Trial Phase for Cosopt
Clinical Trial Phase Trials
Phase 4 17
Phase 3 5
Phase 2/Phase 3 1
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cosopt
Clinical Trial Phase Trials
Completed 25
Unknown status 4
Terminated 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cosopt

Sponsor Name

Sponsor Name for Cosopt
Sponsor Trials
Alcon Research 8
Merck Sharp & Dohme Corp. 6
Pharmaceutical Research Network 4
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cosopt
Sponsor Trials
Other 25
Industry 21
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Moodys
Medtronic
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.